B. suis is commonly distributed by domesticated pigs and wild boars (members of sus scrofa). However, it has also been observed to be carried by caribou, reindeer, and domesticated animals such as cats and rabbits. Other members of the brucella species, such as B. canis, are most commonly carried by their respective animal counterparts (in this example, dogs).
Initially, only three species of Brucella were known to cause infertility and reproductive losses in livestock. However, since the early 1960s, at least 7 new species have been identified and researched. As of today, there are currently ten known species of Brucella: B. abortus, B. suis, B. ovis, B. melitensis, B. canis, B. neotomae, B. pinnipedealis, B. ceti, B. microti, and B. inopinata; three of which have the potential to cause pathogenesis in humans.
BSL level: 3
Agar type: Brucella agar; Liver infusion agar
Growth condition: Aerobic
Growth procedure: Methods of culturing Brucella species remain generally the same with minor differences in the type of blood infused into the growth medium. For B. suis, agar plates infused with 5-10% sterile defibrinated blood need to be incubated at 35C for 24-72 hours in an anaerobic atmosphere supplemented with CO2.
Domain: Bacteria
Phylum: Proteobacteria
Class: Alphaproteobacteria
Order: Rhizobiales
Family: Brucellaceae
Genus: Brucella
Species: B. suis
Brucella species are generally gram-negative, faculative coccobacilli. B. suis is no exception.
Gram stain of B. suis
Scanning electron microscope of B. abortus
Growth on blood agar
(left) Growth on MAC, red indicator - PH less than 6, gram negative
DNase negative - no degradation of DNA
No growth on mannitol - not staphylococci
Catalase positive
Urease positive
Negative phenol red broth - no fermentation
SIM medium deep agar - negative, non-motile
Oxidase positive - aerobic
No growth in anaerobic chamber - aerobic
Negative gram stain - thin peptidoglycan layer
Possible 16s primers: Nes2, Nes1, Det, Mar, EFQ1
16s primer used: Mar
Melting temperature (forward): 54.8C
Melting temperature (reverse): 55.3C
GC content (forward): 50%
GC content (reverse): 48%
In silico PCR
Some members of the brucella species causes brucellosis, which is a bacterial disease that primarily causes reproductive losses in animals. It is considered one of the most common zoophilic infections worldwide, capable of inducing chronic morbidity as well as demanding a complex treatment schedule to eradicate the infection. In humans, brucellosis (also called Mediterranean fever) is contracted by consuming unpasteurized milk, undercooked meat, or coming in contact with an infected animal’s secretions. Contracting brucellosis is preventable by properly handling animal-based products before consumption.
Brucellosis in humans is primarily caused by B. melitensis, B. suis, and B. abortus.
Chills
Fever
Sweating
Joint, muscle and back pain
Headaches
Rashes
In uncomplicated brucellosis cases, a doxycycline-aminoglycoside combination is used as treatment. Alternative regimens include doxycycline-rifampin and doxycycline-cotrimoxazole.
A study conducted in 1999 concluded that human monocytic cells experienced delayed apoptosis when infected with B. suis bacterium through a TNF-a-independent mechanism that does not involve LPS. Cells infected with B. suis became resistant to gamma interferon, which suggested that certain cytotoxic processes were impaired during Brucella infection. This implies that B. suis not only prevents the elimination of infected cells, but additionally prolongs its host cell’s lifespan to its advantage.
Olsen SC, Palmer MV. 2014. Advancement of knowledge of Brucella over the past 50 years. Vet Pathol. 51(6):1076-89. DOI:10.1177/0300985814540545
Tessaro SV, Forbes LB. 1986. Brucella Suis Biotype 4: A Case of Granulomatous Nephritis in a Barren Ground Caribou (Ranger Tarandus Groenlandicus L.) With a Review of the Distribution of Rangiferine Brucellosis in Canada. Journal of Wildlife Diseases. 22(4):479-483. DOI: 10.7589/0090-3558-22.4.479
Galinska EM, Zagorski J. 2013. Brucellosis in humans - etiology, diagnostics, clinical forms. Ann Agric Enviorn Med. 20(2):233-238. PMID: 23772567
Alavi SM, Alavi L. 2013. Treatment of brucellosis: a systematic review of studies in recent twenty years. Caspian J Intern Med. 4(2): 636–641. PMCID: PMC3755828
Gross A, Terraza A, Ouahrani-Bettache S, Liautard JP, Dornand J. 1999. In Vitro Brucella suis Infection Prevents the Programmed Cell Death of Human Monocytic Cells. 68(1):342-345. DOI:10.1128/IAI.68.1.342-351.2000
Moulana Z, Roushan MRH, Marashi SMA. 2016. Evaluation of different primers for detection of brucella using PCR method. Electron Physician. 8(11): 3222–3227. PMCID: PMC5217814
Zimbro, Mary J, Power, David A, Miller, Sharon M, Wilson, George E, Johnson, JA, Difco & BBL Manual (2ed), in press. Becton, Dickinson and Co., Sparks, MA
UF 2022 graduate
Third year microbio major
Premed
Bilingual in Chinese and English
Takes art commissions in free time